Potassium guaiacolsulfonate

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Summary

Potassium guaiacolsulfonate is a mucolytic and expectorant indicated to relieve a productive cough.

Generic Name
Potassium guaiacolsulfonate
DrugBank Accession Number
DB13735
Background

Guaiacolsulfonate is an aromatic sulfonic acid. Potassium guaiacolsulfonate salt is an expectorant that thins the mucus in the lungs and reduces chest congestion.

Type
Small Molecule
Groups
Experimental
Synonyms
  • Guaiacolsulfonate potassium
  • Potassium sulfoguaiacolate

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Associated Conditions
Indication TypeIndicationCombined Product DetailsApproval LevelAge GroupPatient CharacteristicsDose Form
Used in combination to treatAllergic coughCombination Product in combination with: Dextromethorphan (DB00514), Chlorpheniramine (DB01114)••••••••••••••••••• ••••••
Used in combination to treatCough caused by common coldCombination Product in combination with: Dextromethorphan (DB00514), Chlorpheniramine (DB01114)••••••••••••••••••• ••••••
Used in combination for symptomatic treatment ofCoughingCombination Product in combination with: Dextromethorphan (DB00514)••• ••••••••
Used in combination for symptomatic treatment ofCoughingCombination Product in combination with: Dropropizine (DB13785)••• ••••••••
Used in combination to treatCoughingCombination Product in combination with: Sodium citrate (DB09154)••• ••••••••
Associated Therapies
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
DrugInteraction
AcebutololPotassium guaiacolsulfonate may increase the hyperkalemic activities of Acebutolol.
AceclofenacPotassium guaiacolsulfonate may increase the hyperkalemic activities of Aceclofenac.
AcemetacinPotassium guaiacolsulfonate may increase the hyperkalemic activities of Acemetacin.
Acetylsalicylic acidPotassium guaiacolsulfonate may increase the hyperkalemic activities of Acetylsalicylic acid.
AlclofenacPotassium guaiacolsulfonate may increase the hyperkalemic activities of Alclofenac.
Food Interactions
Not Available

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Active Moieties
NameKindUNIICASInChI Key
Potassium cationionic295O53K15224203-36-9NPYPAHLBTDXSSS-UHFFFAOYSA-N
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
ANTIBEKSIN SURUP, 100 MLPotassium guaiacolsulfonate (175 mg/5ml) + Ephedrine hydrochloride (5 mg/5ml) + Pheniramine maleate (15 mg/5ml) + Sodium citrate (65 mg/5ml)SyrupOralYAVUZ İLAÇ ECZA DEPOSU MEDİKAL ÜRÜNLER SAN.VE TİC. A.Ş.2009-02-06Not applicableTurkey flag
ARTU 100 ML SURUPPotassium guaiacolsulfonate (175 mg/5ml) + Sodium benzoate (5 mg/5ml) + Ephedrine hydrochloride (5 mg/5ml) + Promethazine hydrochloride (5 mg/5ml)SyrupOralGÜNSA GÜNEY İLAÇ VE HAMMADDELER SAN. VE TİC. A.Ş.1972-03-16Not applicableTurkey flag
GAYABEN 150 ML SURUPPotassium guaiacolsulfonate (133.3 mg) + Diphenhydramine hydrochloride (10 mg) + Guaifenesin (100 mg) + Pentoxyverine citrate (8.3 mg)SyrupOralBİLİM İLAÇ SAN. VE TİC. A.Ş.1968-07-29Not applicableTurkey flag
ดูทรอส เอ็กซ์Potassium guaiacolsulfonate (200 mg/5mL) + Bromhexine hydrochloride (4 mg/5mL)Syrupบริษัท ไทยนครพัฒนา จำกัด2013-02-06Not applicableThailand flag
ทอไกลโคโล่Potassium guaiacolsulfonate (200 mg/5mL) + Bromhexine hydrochloride (2 mg/5mL)Syrupบริษัท สยามเภสัช จำกัด1985-09-17Not applicableThailand flag
Unapproved/Other Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
P-TussPotassium guaiacolsulfonate (300 mg/5mL) + Hydrocodone bitartrate (5 mg/5mL)LiquidOralPrasco, Laboratories2010-12-012011-01-21US flag
Phenylephrine Carbetapentane Potassium GuaiacolsulfonatePotassium guaiacolsulfonate (100 mg/5mL) + Pentoxyverine (20 mg/5mL) + Phenylephrine (10 mg/5mL)LiquidOralRiver's Edge Pharmaceuticals, LLC2010-03-012010-11-20US flag

Categories

Drug Categories
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
21A795TNZD
CAS number
1321-14-8

References

General References
  1. AIFA Package Leaflet: CORYFIN SEDATIVO FLUIDIFICANTE (dextromethorphan and potassium guaiacolsulfonate) oral syrup [Link]
PubChem Substance
347911449
RxNav
91275
Wikipedia
Guaiacolsulfonate

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
Suspension
Solution / dropsBuccal
LiquidOral
SyrupOral
Syrup
Tablet, sugar coatedOral
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
Not Available
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
Not Available
Chromatographic Properties
Collision Cross Sections (CCS)
Not Available

Drug created at June 23, 2017 20:47 / Updated at May 22, 2021 06:01